Viyash Scientific's Alivira to Acquire Italy's BioForLife for Rs 188 Crore, Expands Pet Care Business
Viyash Scientific Limited’s subsidiary Alivira Animal Health Limited has agreed to acquire 100% stake in Italy’s BioForLife Italia S.r.l. for Rs 188 crore, expanding its pet care business. The deal, expected to close in Q2 FY27, marks Viyash’s entry into the European pet care market through a leading Italian company based in Milan.
Viyash Scientific Limited, through its wholly owned subsidiary Alivira Animal Health Limited, has signed a binding agreement to acquire 100% equity stake in BioForLife Italia S.r.l. (BFL), a Milan-based pet care company. The acquisition, valued at Rs 188 crore, is set to close in the second quarter of fiscal year 2027 (Q2 FY27). Alivira, a subsidiary of Viyash Scientific, specializes in animal health solutions, and this deal will strengthen its presence in the global pet care sector. BioForLife Italia is recognized as a key player in the European pet care market, with a focus on innovative products and services. The transaction underscores Viyash Scientific’s strategic expansion into international markets, particularly Europe, by leveraging BFL’s established operations in Italy. The acquisition will enable Alivira to enhance its product portfolio and market reach, catering to growing demand for premium pet care solutions. BioForLife Italia’s headquarters in Milan positions the company as a strategic asset for Alivira’s European ambitions. The deal reflects a broader trend of Indian companies acquiring foreign firms to accelerate growth in niche sectors like pet care. Industry observers note that this acquisition aligns with the rising demand for specialized animal health products globally. Viyash Scientific’s move is expected to solidify its position as a key player in the pet care industry, both domestically and internationally.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.